PEGylated Proteins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2022 - 2032
The global PEGylated proteins market was initially evaluated at US$ 4.5 million in the base year of the study i.e. 2019. The research report predicts that the global PEGylated proteins market will record an incredible compound annual growth rate of 7.0 % during the forecast period of 2020 to 2027.
Furthermore, it also projects that the global PEGylated proteins market will expand to hit the final evaluation of US$ 6.4 million by the end of the forecast period in 2027. The leading players in the global PEGylated proteins market offer various types of consumables, including reagents as well as PEGylation kits.
Some of the key applications for the solutions in the global PEGylated proteins market include chronic kidney diseases as well as cancer treatment.
Key end users for the products and solutions provided by the manufacturers and leading players in the global PEGylated proteins market include biotechnology companies as well as pharmaceutical companies.
The rising expenditure aimed at furthering the research and development in biotech as well as pharmaceutical companies is propelling the sales of global PEGylated proteins market.
Furthermore, the increasing prevalence of lifestyle diseases as well as the rising adoption of protein based drugs are influencing the global PEGylated proteins market outlook in coming years.
The development of the healthcare industry and the introduction of new drugs and therapeutics are the key factors estimated to encourage the growth of the global PEGylated proteins market in the next few years.
The rising number of lifestyle disorders and the growing demand for effective therapeutics are boosting the demand for PEGylated proteins. In addition, the increasing focus on research and developing activities and innovations is estimated to generate promising growth opportunities for the leading players operating in the PEGylated proteins market across the globe in the near future.
The rise in the adoption rate of protein-based drugs in comparison with non-protein base drugs, owing to its effectiveness and the rising stability of protein are projected to fuel the development of the global PEGylated proteins market in the coming years.
On the contrary, the rising issues related to the product recalls and drug failure are expected to curb the growth of the overall market. Nonetheless, the key players in the market are focusing on untapped markets across the globe in order to enhance their market presence and attract a large number of consumers.
Furthermore, the presence of a strong pipeline and the rising emphasis of key players on the development of effective new products are estimated to augment global market in the coming years. The availability of enhanced healthcare infrastructure in developed economies is expected to contribute widely towards the expansion of the global PEGylated proteins market in the near future.
In addition, the increasing number of end users and the rising number of market players are estimated to accelerate the development of the overall market.
Proteins have found application in the therapeutics industry for long and are much sought after in modern medicine too. This has resulted in a growing number of protein-based drugs in market these days. However, there are quite a few pressing problems associated with their use such as swift degradation and excretion from patients, requiring frequent dosing. This ups the cost of therapy. To tackle the challenege, a polyethylene glycol (PEG) group is linked to the protein in a process called PEGylation. The global PEGylated proteins market is slated to tread on a healthy growth path in the near future on account of PEG's potential to protect against protein enzymatic degradation and prolong the half-life of drugs.
In the research report, TMR Research provides a detailed analysis of the opportunities present the global PEGylated proteins market. It segments the global market based on various parameters such as products, protein types, application, and end users. It also studies the different growth drivers and restraints affecting the competitive dynamics in the market and its growth prospects in the years ahead.
One of the primary reasons for the popularity of PEGylated proteins is their ability to bolster protein stability and circulate half-life. This unique perceived benefit has majorly contributed to the global PEGylated proteins market. Besides this, other factors stimulating the market are the rising investment in research and development by pharmaceutical and biotechnology companies, expansion in the biologics sector, increasing instances of lifestyle-related diseases, and swifter uptake of protein based drugs compared to non-protein based drugs.
Countering the growth in the market, however, are drug failures and recalls. A current noticeable trend in the market is the dominance of the consumables products segment over the services segment due to the rising uptake of kit-based PEGylation products. Further, among the different end users in the market, namely academic research institutions, pharmaceutical and biotechnology companies, and CROs, the pharmaceutical and biotechnology companies account for maximum share because of their higher spend on research and development. Depending upon the type of protein, the market can be segmented into interferons, colony stimulating factors, erythropoietin, mAbs, and recombinant factor VIII. Of these, colony stimulating factors is poised for growth in the upcoming years.
Based on geography, the global market for PEGylated proteins market can be segmented into Europe, North America, Asia Pacific, and the Rest of the World. Among them, North America accounts for maximum share in the market. Some of the prominent growth drivers responsible for the stellar growth in the market in the region are growing take-up of biologics drugs such as erythropoietin, monoclonal antibodies, and interferon for treating chronic ailments and strong government funding and grants for research activities.
To present an in-depth assessment of the competition prevailing in the global market for PEGylated proteins, the report profiles companies such as Thermo Fisher Scientific, Inc., Merck Millipore, NOF Corporation, Creative PEGworks, Quanta BioDesign, Ltd., and Biomatrik, Inc.
The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach. The researchers compile the necessary information that enlightens the CXOs about the current growth opportunities in a specific market and enables them to make the most of the opportunities.
TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others. TMR Research reports help the stakeholders and CXOs make impactful decisions through a unique blend of innovation and analytical thinking. The use of innovation and analytical thinking while structuring a report assures complete and ideal information of the current status of the market to the stakeholders.
TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others.
5-Point Growth Formula
The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs.
The 5-point growth formula includes the following points:
Current and Future Threats
Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats.
Accurate Trend Analysis
Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues.
Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market.
The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation.
The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly.
The reports offer answers to the top 7 questions that revolve around the growth of the market
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report